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In Pennsylvania, cancer patients experience disparate cancer-related health outcomes. Patient navigation, a
patient-centered evidence-based approach eﬀectively addresses barriers to care, and reduces cancer-related
disparities and burden. We performed a literature search with speciﬁc inclusion and exclusion criteria to identify
literature emanating from the United States which potentially described the development, eﬃcacy and cost
eﬀectiveness of patient navigation across the United States and in Pennsylvania. The results from this review
signiﬁed that, over last two decades there has been a rapid growth in the ﬁeld of patient navigation programs
across the United States which includes the state of Pennsylvania. However, despite the presence of these
programs and navigators, Pennsylvania does not have state-wide guidelines which could deﬁne patient navigation and recognizes a patient navigators as well as roles and responsibilities. This paper calls for a policy-based
approach to recognize and standardize patient navigation in Pennsylvania. We recommend the Pennsylvania
Department of Health propose legislation which would help deﬁne patient navigation and patient navigator. We
also urge various organizations, policy makers, state and private insurers, and funding agencies in Pennsylvania
to recognize, acquire, and cultivate a culture of patient-centeredness through patient navigation.

1. Background

1.1. Cancer-related disparities

Despite cancer mortality decreasing by 29% from 1991 to 2017,
cancer still remains the second most common cause of death in the
United States (US), exceeded only by heart disease [1]. According to the
American Cancer Society (ACS), more than 1.8 million new cancer
cases are expected to be diagnosed in the US during 2020 [2]. In 2020
alone, approximately 606,520 US residents will die from cancer, which
translates to about 1660 deaths per day [2]. Pennsylvania has the third
highest cancer incidence rate nationally, and the second highest among
states in the Northeast [3]. In 2020, Pennsylvania is estimated to have
approximately 80,240 new cases and 27,860 deaths [2]. The medical
costs and lost productivity from cancer in Pennsylvania are estimated to
be $7.3 billion each year [4]. Over the last two decades there has been
signiﬁcant advances in cancer screening and treatment which has resulted in overall reduction in morbidity and mortality among those
diagnosed with cancer. However, there still exists disparities in receiving this recommended screening, care, and treatment [1,5–8].

Although there are signiﬁcant medical and technological advancements aﬀorded by the American healthcare system, the fractured infrastructure can make it diﬃcult for patients to access and manage their
care and treatment [9]. As per the National Cancer Institute (NCI),
cancer disparities are thought to reﬂect the interplay of social, economic, cultural, environmental, diet, biological, and health system
factors [8]. While the reasons for these cancer-related disparities are
complex and not completely understood, research has identiﬁed numerous patient, provider, and health system barriers for these at-risk
populations [10,11]. Across the US, these barriers include low health
literacy, delays in early diagnosis and treatment, access to services,
transportation, inadequate health insurance, and other structural, and
personal obstacles to health care [2,6]. In Pennsylvania, residents of the
52 Appalachian counties experience excess cancer burden due to
transportation and ﬁnancial barriers, as well as limited availability of
certiﬁed cancer screening facilities, oncologists and primary care providers [12]. There has also been an growing body of evidence which
indicates that cancer-related barriers interfere with timely access to
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3. Results

diagnosis and treatment and could possibly lead to negative health
outcomes [6,13]. Hence, in recent years, reducing cancer disparities has
become an overarching goal of policy-makers and researchers.

3.1. Rise of patient navigation research & programs across the United States
Since 1990, PN has been a model of care that expanded rapidly in
underserved communities and medical institutions across the US
[13,14]. The National Cancer Institute’s (NCI) 2003 survey reported
more than 200 cancer care programs across the US which provided
some form of PN to cancer patients [18]. The ﬁrst substantial research
grant for PN came in the year 2005, when NCI along with the ACS
provided $25 million to 9 sites in the Patient Navigation Research
Program (PNRP) initiative [19]. The purpose of this initiative was to
evaluate the eﬃcacy and cost-eﬀectiveness of cancer-related PN [19].
Further, the federal legislative and executive agencies were also involved in the advancement of cancer-related PN across the US [20]. The
Patient Navigator and Chronic Disease Prevention Act of 2005 further
resulted in $2.4 million grant from the Health Resources and Services
Administration (HRSA) [20]. Six two-year demonstration programs
were funded by the Health Resources and Services Administration
(HRSA) in 2008 to support lay patient navigators who provide services
that focused on a wide variety of health conditions (e.g., cancer, heart
disease, diabetes, hypertension, obesity, asthma) [13,14]. By 2010, the
number of PN demonstration projects funded by HRSA increased to ten
[14].
Further, through their National Breast and Cervical Cancer Early
Detection Program (NBCCEDP), the Centers for Disease Control and
Prevention (CDC) provides PN services to overcome the barriers and
help low-income, uninsured, and underinsured women gain access to
timely breast and cervical cancer screening, diagnostic, and treatment
services [21]. Currently, the NBCCEDP funds 70 grantees–all 50 states,
the District of Columbia, 6 US territories, and 13 American Indian/
Alaska Native tribes or tribal organizations [21]. Also, until 2018, the
ACS had funded more than 80 patient navigation programs across the
United States [22]. The increase in PN programs and research was directly related to the federal and private foundation funding [18]. Several studies across the US including Pennsylvania have described the
eﬃcacy of PN, and its cost eﬀectiveness; we have summarized a few
below to provide evidence for PN programs across the US and particularly in Pennsylvania.

1.2. Patient navigation
Patient navigation (PN) has been demonstrated to be an eﬀective
and scalable intervention model to overcome these disparities and
barriers [6,7,13–16]. Dr. Harold Freeman, a pioneer in PN, deﬁned PN
as, “a community-based service delivery intervention designed to promote
access to timely diagnosis and treatment of cancer and other chronic diseases
by eliminating barriers to care” [17]. People who practice PN, are known
by various names, including, but not limited to, patient navigator, nurse
navigator, social worker, outreach worker, community health worker
(CHW), and promotora (Spanish term for “CHW”). Patient navigators
play an important role in addressing these challenges by educating
people about cancer prevention and screening, connecting patients to
healthcare providers, providing linkages to ﬁnancial and community
resources, and navigating patients through the healthcare system [9].
Over last two decades, there has been a rapid growth of patient
navigation programs across the US [14]. However, despite the presence
of these programs and navigators, there are many states in the US which
do not have state-wide guidelines that deﬁne patient navigation and
recognize patient navigators and their roles and responsibilities. Despite the presence of several PN programs, Pennsylvania lacks statewide
PN guidelines. The objective of this paper is to address this gap, describe the existing literature on PN research and programs across the US
and speciﬁcally in the state of Pennsylvania, and call for a policy-based
approach to recognize and standardize PN in Pennsylvania. We recommend the PA Department of Health propose a legislation which
would help deﬁne PN and patient navigator. Finally, we also urge
various organizations, policy makers, state and private insurers, and
funding agencies in PA to recognize, acquire, and cultivate a culture of
patient-centeredness through patient navigation.

2. Methods
There have been several authors who have conducted full literature
reviews of PN research and implementation programs across the US.
The primary focus of the current paper is, however, not to conduct a
literature review on PN research and programs. We aim to highlight the
development of PN programs across US and more particularly in
Pennsylvania so that, based on this available evidence appropriate
policy recommendations for the state of Pennsylvania could be suggested. As part of the methodology, this paper followed a two-step miniliterature review process. In the ﬁrst step, on-line resources such as
PubMed, Google Scholar, and Penn State Library Resources were searched to ﬁnd appropriate US based peer-reviewed literature with a
limitation to English language. Searches were conducted using combinations of the following key words: “patient navigation”, “Cancer”,
“policy”, “patient navigator” and “health disparities”. Previously identiﬁed key publications relevant and suited to the inclusion criteria were
also used in the literature review.
In the second stage, we screened all identiﬁed references and categorized them in separate groups such as development of PN funding
across the US, eﬃcacy of PN, socioeconomic beneﬁts of PN, and PN
programs or studies conducted in Pennsylvania. Both qualitative and
quantitative research were considered for this paper. The literature was
restricted to the last three decades to stay current with government
policy and studies on cancer PN. The literature selected included crosssectional studies, randomized control trials, systematic reviews, brief
reports, news articles, published program evaluations, policy briefs, and
government and non-government organizations reports.

3.2. Eﬃcacy of patient navigation
Year after year this rising trend of PN programs across the US have
beneﬁted thousands of cancer patients. PN has shown to be eﬀective in
screening, diagnostic resolution, treatment and clinical trial enrollment
[13,14,23].
3.2.1. Screening
The comprehensive Breast and Cervical Cancer Control Navigation
Program (BCCCNP) of the Michigan Department of Health and Human
Services (MDHHS) alone has provided breast and cervical cancer
screenings to more than 656,439 women and diagnosed 4873 breast
cancers and 6453 cervical cancers [24]. Since 2015, approximately
173,000 people across the US have relied on the PN program to help
them through screening, diagnosis and treatment [2,25–27]. These PN
programs were delivered by patient navigators from several educational
backgrounds towards an increase in screening and early detection of
cancer [13,14].Two systematic reviews have reported that PN improved cancer screening rates in the range of 10.8%–17.1% for three
major cancers namely breast, cervical and colorectal [13,14]. Besides,
adherence to follow up visits following a screening abnormality have
been reported to increase in the range of 21%–29.2% [13,14]. The
evaluation of PNRP revealed that. PN increased rates of resolution of
abnormal cancer screening ﬁndings and decreased the time it typically
takes patients to receive a diagnostic resolution [28]. The rates of
treatment initiation were also increased among patients who typically
2
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reported that for each disease subset, except melanoma, patients in the
PN program had a reduction in health care usage in the acute care
setting (P < .001) [35]. Another study reported 52% increased likelihood of a 30-day all-cause readmission among the patients who did
not receive PN services (P = .04) [35].
Improved patient-related outcomes such as patient satisfaction,
patient perceptions of PN, timeliness of care, care quality, adherence to
screening, appointments, treatments and quality of life are also found to
be cost-eﬀective and contribute towards net ﬁnancial gains [19,35,37].
One such example is Sarah Cannon, the Cancer Institute of HCA
Healthcare which had a PN program that supported 65 hospitals across
seven states [35]. These hospitals provided PN to more than 15,000
patients in 2018 and within a year, 59% growth in patient enrollment to
PN program was observed, correlating with increased patient volumes.
Additionally, another important quality measure at these hospitals was
time from ﬁrst diagnosis to ﬁrst treatment, where the goal of less than
30 days was met across all disease sites. Another program at three
hospitals in New York reported PN to be associated with a 61% increase
in average monthly colonoscopy volume yielding a net ﬁnancial beneﬁt
to the hospitals [38].
PN programs also signiﬁcantly reduced medical treatment costs and
potentially provided cost savings to the health care payer [39]. An
economic evaluation of PN conducted at 3 community hospitals revealed that, PN helped in achieving a cancer diagnostic resolution
which eventually resulted in decreased medical costs by $511 to $2080
per patient with breast cancer and by $1192 to $9708 per patient with
colorectal cancer [40]. The average cost savings ranged from $528 to
$781 per quarter per patient [39]. A pilot program at Northern California Healthcare Organization found that 35% fewer patients were lost
to other health systems if they were in the PN program from the point of
a suspicious cancer ﬁnding [35]. Lastly, PN programs reduced future
incident cancer diagnoses and improved timely diagnostic resolution,
and substantial future cost savings could be projected [41].

failed to begin treatment within 90 days of a cancer diagnosis [28]. In
Texas, a three-year community-based PN program reported increased
uptake and adherence for cervical cancer screening among Hispanic
women resulting in a per capita gain of 0.2 years of life expectancy
[29].
3.2.2. Diagnostic resolution
A randomized control trial conducted among racially/ethnically
diverse inner city population in Boston, showed a signiﬁcant decrease
in time to diagnosis for subjects in the navigated group with a cervical
and breast cancer screening abnormality [30]. The systematic review
on eﬃcacy of PN revealed that more than 25 articles focused on the
eﬀect of PN on the diagnostic resolution or timely follow‐up of an abnormal test result and reported a favourable impact of PN interventions
on diagnostic resolution in comparison with usual care [23]. These
studies showed that compared with patients receiving usual care, patients in the PN group experienced a shorter length of time to follow‐up
and higher rates of completion of appropriate follow‐up/attendance to
scheduled appointments. Further, several systematic reviews have also
covered other studies which were focused on medically underserved
areas, uninsured populations, or rural Appalachian populations and
overall even these studies suggested that PN was eﬀective in increasing
rates of diagnostic resolution consistently across diverse populations
[13,14,23].
3.2.3. Treatment and patient satisfaction
Studies have also reported positive impact on cancer treatment,
including a shorter time to treatment initiation, higher rates of treatment reception or adherence and increased patient satisfaction with
cancer care [13,14,23]. PN can also contribute to enhanced relationships between patients and the health care team and may help increase
patient satisfaction by reducing barriers and promoting patient-centeredness in the care process [31]. A qualitative study while highlighting the experiences of various patients through the cases presented
found that, patient navigators tailored navigation strategies to guide
each patient and aid them in overcoming the oftentimes fragmented,
complex, or confusing system of care [32]. These tailored strategies
ranged from researching aﬀordable housing, transportation, and prescription options to helping patients apply for health insurance and
developing critical bonds with local health clinics and community organizations to improve patients’ access to resources· Additionally, PN
has also been seen eﬀective in improving the underrepresentation of
racial and ethnic minorities in clinical trials [23,33]. PN increased
enrollment into clinical studies in a county hospital setting serving
minority and underserved population [34]. Other studies found that PN
interventions resulted in higher rates of attendance to medical appointments, lower rates of hospitalization, and fewer intensive care unit
admissions and emergency room visits [35].

3.4. Cancer-related patient navigation programs and services in
Pennsylvania
The Penn State Cancer Institute (PSCI) has been actively involved in
training of patient navigators. They have trained more than 80 patient
navigators across Pennsylvania [42]. In July 2017, the PSCI developed
the Cancer Navigation and Survivorship Network (CaNSuN) to increase
engagement among the community of navigators throughout Pennsylvania [42].The purpose of this network is to create a platform for research, help disseminate best navigation practices, increase the
knowledge base of navigation methods, develop a local network among
navigators, and provide community support to navigators [42]. The
PSCI also launched a Story Map, The Story of Cancer in Central Pennsylvania in 2018 [43]. This highly interactive educational tool can be
viewed by individuals interested in learning more about the disease and
how navigation can help patients overcome barriers to care. This data
storytelling technology communicates important information to patients, navigators, and key stakeholders, while eﬀectively aiding in the
broader implementation of ground-breaking health care initiatives and
research.
In addition, a group of investigators at Penn State College of
Medicine has conducted a randomized study (n = 60) to test the feasibility of PN to overcome barriers to cancer-related care, for women
with dense breast tissue. Women found to have dense breast tissue on a
screening mammogram have 2–6 times increased risk of developing
breast cancer. The study examined two questions: (1) whether a 12week telephone-based navigation for women with dense breast tissue
improves knowledge, attitude, and behaviours related to dense breast
tissue, compared to usual care; and (2) if navigation changes the rate at
which women receive supplemental breast cancer screening, compared
to usual care. The study results suggest that PN is a feasible option to
improve knowledge, attitude, and behaviours for women with dense

3.3. Cost eﬀectiveness of patient navigation
Apart from the early screening and treatment beneﬁts, PN can also
be an eﬀective business strategy for cancer care. PN has the potential to
increase top-line revenue in a fee-for-service (FFS) payment system and
decrease costs in a bundled payment system [35]. Scientiﬁc literature
clearly demonstrates a positive return on investment (ROI) for patients
in a PN program in an alternative payment model systems, as well as in
health systems operating in a FFS environment [35]. The University of
Alabama study on cost eﬀectiveness found that PN yielded a 1:10 ROI,
with average costs for patients receiving PN declining by $781.29 per
patient per quarter and saving of $19 million annually across the network [35]. Another study conducted at Michigan’s Grand River Gastroenterology Institute identiﬁed that, only addressing the transportation barrier with the help of PN, the colonoscopy cancellation rate
decreased by 54% and yielded an estimated annual saving of $168,152
[36]. The Levine Cancer Institute (LCI), based in Charlotte, NC,
3
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of patient navigators across all the states in the US has also been endorsed under the Patient Protection and Aﬀordable Care Act (ACA),
Public Law 111−148. The law recommends strengthening the role and
formal recognition of patient navigators in the health care system of
every state [49,50].
Apart from the recognition there are concerns over insurance reimbursement of patient navigators. Despite of a growing body of evidence from the US which supports the ﬁnancial beneﬁts of navigators to
health systems including insurance companies, Medicare and many
commercial insurance companies do not directly pay for PN services
[35]. In fact, according to the Pennsylvania Department of Health, the
state and private insurance companies in Pennsylvania may be overspending on cancer treatment and rehabilitation [4]. If insurance providers cover the reimbursement for accessing PN among cancer patients, it could potentially in return receive beneﬁts in reducing future
treatment costs through increased screening uptake and early detection
and treatment. In addition, this PN policy on formal recognition of
patient navigators in Pennsylvania could potentially encourage hospitals and organizations to recruit a navigator work force to serve patients. This initiative could not only beneﬁt patients, but could also
provide a positive return of investment to the hospitals through increased screening rates and reductions in emergency and recurrent
admissions costs [31,35,36,38,39,45]. This beneﬁt has also been voiced
by the ACA which recommends every state health insurance exchange
to establish a “navigator program” to help individuals and insurance
businesses [49]. After reviewing the literature on PN across the US and
also more particularly in Pennsylvania, we recommend the following
policy solutions for the continuum of cancer care in Pennsylvania.

breast tissue, and that the navigation helped resolve the barriers that
participants report; however, not every participant indicated that they
had barriers to address.
At Penn Medicine, a retrospective and observational study
(n = 13,241) conducted at three of their Health System hospitals reported that patients assisted by PN (22%, n = 2996) across all cancer
types were 10% more likely to stay for treatment compared with those
not in the PN program [35]. Further, the PN supported patients also
reported an increased utilization of treatment services. Another study
(n = 125) at Penn Medicine conducted to determine the feasibility,
acceptability and use of the PN program reported that, 46 patients who
completed PN-supported colonoscopy screening had at least one adenomatous (precancerous) polyp and of them 3 patients were later diagnosed with cancer [44]. Further, when the study evaluated the program satisfaction levels, overall 92% of the patients in this study were
highly satisﬁed with the program and 36% of the patients who completed the program stated they would have been, “highly unlikely to
have completed the colonoscopy without the patient navigator” [44].
In Western Pennsylvania, PN pilot programs in three hospitals found
a 43% reduction in non-emergent emergency department use among
frequent users [45]. In addition, the hospitals also showed 60% reduction in 30 days readmission across target diagnosis-related groups
resulting in reduced ﬁnancial penalties for readmissions. Given the
costs associated with acute care and penalties for excess 30-day readmissions under the Centers for Medicare & Medicaid Services (CMS)
Hospital Readmissions Reduction Program, these results indicate that,
engaging navigators may help reduce hospital costs [35]. Also, Accenture in collaboration with Highmark Foundation has developed lay
PN pilot programs in three Western Pennsylvania hospitals, targeting
priority areas and patient populations based on the health needs of the
communities [45]. PN is also a part of the University of Pittsburgh
Medical Center (UPMC) and aims to provide individualized assistance
to the patients, families, and caregivers throughout the health care
experience [46]. The Fox Chase Cancer Center, Philadelphia, also receives funding from National Breast Cancer Foundation for its PN
program [47]. This program provides cancer education, screening and
outreach services to the community, with a special focus on reaching
underserved populations [47]. In another project, Pennsylvania’s
Healthy Woman Program trained and paid for two navigators to help
immigrant patients (n = 138) over a 4-month period [48]. Among
them, 88 were screened by the Healthy Woman Program and 40 made
appointments on dates even after the project ended.

4.2. Policy recommendations
This paper urges the Pennsylvania Department of Health, various
health organizations, policy makers, state and private insurers, and
funding agencies in Pennsylvania to recognize, acquire, and cultivate a
culture of patient-centeredness through patient navigation. If each were
to support in their respective capacity, Pennsylvania could beneﬁt from
the following policy recommendations.

• The Pennsylvania Department of Health is recommended to propose

4. Discussion
4.1. Policy-based approach to cancer-related patient navigation in
Pennsylvania
The scientiﬁc literature supports the eﬀectiveness of PN in addressing cancer burden and disparities. However, despite the enormous
evidence supporting PN across the US, including the state of
Pennsylvania, there are no state-wide guidelines in Pennsylvania which
deﬁnes PN and recognizes the patient navigator and their roles and
responsibilities. Additionally, PN is not a consistently recognized profession in Pennsylvania and hence individuals with various backgrounds ﬁll the navigator roles. Although individuals who practice PN
may possess diﬀerent sets of skills, training, and education, however,
each one has valuable expertise to oﬀer patients. Furthermore, given
this heterogeneity in the background and role of the patient navigator,
it becomes all the more diﬃcult to identify guidelines applicable to
various situations and individuals [49].This identity crisis of the patient
navigator in Pennsylvania could possibly be addressed through their
formal recognition within our healthcare system. The policy for recognizing the work of patient navigators in Pennsylvania could further
enhance their work and contribute towards bridging the gap between
patients and the complex cancer-care system. This need for recognition

•
•

state legislation to deﬁne the term ‘PN’ & ‘Patient Navigator’ based
on the deﬁnition provided under the Patient Navigator Outreach &
Chronic Disease Prevention Act of 2005, 109, P.L. 18, 119 Stat. 340
[51]. It is also recommended to follow the same statute and enlist
the duties performed by them and help patient navigators gain the
essential recognition in the existing state’s health care workforce
and state’s human health services. Once the standard criteria is
formulated and the recognition has been established, licensure may
be the next step.
We urge state and private insurers to provide direct reimbursement
for PN services and include it as an integral part of the health insurance programs.
At an organizational level, we recommended that employers and
funders recognize patient navigators’ contribution to the public
health and healthcare infrastructure by compensating them at
competitive wage levels. Navigators should also be provided employee beneﬁts comparable to those received by other health professionals. Employers are also recommended to support PN career
development and formation of state and local patient navigators’
networks and associations for purposes of mutual support, advocacy, and professional development.
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